BC Platforms, a company that focuses on genomic data managements and analysis, has announced that it has partnered with Pfizer to generate real world evidence (RWE) in atrial fibrillation patients
The collaboration will see BC Platforms analyse anonymised data from Turku University Hospital, in Finland, alongside other health care providers to develop RWE for the use of treating cardiovascular diseases.
